Trial Profile
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Angina pectoris; Myocardial infarction; Postmyocardial infarction; Unstable angina pectoris
- Focus Therapeutic Use
- Acronyms ARMYDA-IMR
- 23 Jan 2013 New trial record